Omeros (OMER) awards VP 105,000 stock options at $9.84 strike price

Rhea-AI Filing Summary

Omeros Corp reported that its VP, Finance & CAO, David J. Borges received a grant of 105,000 stock options for common stock at an exercise price of $9.84 per share, expiring on July 22, 2036. One-third vests on August 1, 2027, with the remainder vesting in 32 equal monthly installments thereafter.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Borges David J.

Role VP, Finance & CAO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy) F1	105,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 105,000 shares (Direct)

Footnotes (1)

1. F1. One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.

Key Figures

Stock options granted: 105000.0000 shares Exercise price: $9.8400 per share Expiration date: 2036-07-22 +2 more

5 metrics

Stock options granted 105000.0000 shares Options for Omeros common stock granted to VP, Finance & CAO

Exercise price $9.8400 per share Price at which options may be exercised

Expiration date 2036-07-22 Date after which unexercised options lapse

Initial vesting date 2027-08-01 One-third of option shares vest and become exercisable

Remaining vesting installments 32 monthly installments Equal installments vesting on first day of each following month

Key Terms

Stock Option (right to buy), exercise price, vest in 32 equal monthly installments

3 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 9.8400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in 32 equal monthly installments financial

"The remaining shares shall vest in 32 equal monthly installments"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/24/2026 - 09:12 PM Accepted by SEC EDGAR 07/24/2026 - 09:11 PM Learn about SEC filing dates

FAQ

What insider transaction did OMER report for David J. Borges?

Omeros (OMER) reported that VP, Finance & CAO David J. Borges received a grant of 105,000 stock options. These options relate to Omeros common stock and represent an equity-based component of his compensation package.

How many OMER stock options were granted to David J. Borges and at what price?

David J. Borges was granted 105,000 stock options tied to Omeros (OMER) common stock at an exercise price of $9.84 per share. This is the price he must pay per share if he later exercises the options.

What is the vesting schedule for David J. Borges’ new OMER options?

One-third of the options will vest on August 1, 2027. The remaining shares will then vest in 32 equal monthly installments on the first day of each month following that initial vesting date.

When do David J. Borges’ OMER stock options expire?

The newly granted Omeros (OMER) stock options to David J. Borges have an expiration date of July 22, 2036. After that date, any unexercised options will cease to be exercisable.

Did the OMER Form 4 report any stock sales or purchases of common shares?

No. The Form 4 for Omeros (OMER) only reports a grant of stock options to David J. Borges. It does not disclose any open-market purchases or sales of Omeros common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Borges David J.

(Last) (First) (Middle)

201 ELLIOTT AVENUE WEST

(Street)

SEATTLE WASHINGTON 98119

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Finance & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$9.84	07/22/2026		A		105,000		(1)	07/22/2036	Common Stock	105,000	$0	105,000	D

Explanation of Responses:

1. One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.

	/s/ Peter B. Cancelmo, Attorney-in-Fact	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)